Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
State Street Financial Select Sector SPDR ETF
XLF
$59.5B
| $7.58M | 0.02% |
395,284
-507,717
| -56% | -$9.34M |
|
|
ICON
952
DELISTED
Iconix Brand Group, Inc.
ICON
| $7.57M | 0.02% |
+19,058
| New | +$7.01M |
|
953
Infosys
INFY
$50.3B
| $7.54M | 0.02% |
1,065,600
-5,804,800
| -84% | -$39.1M |
|
|
AF
954
DELISTED
Astoria Financial Corporation
AF
| $7.51M | 0.02% |
543,050
+219,900
| +68% | +$2.94M |
|
|
OKS
955
DELISTED
Oneok Partners LP
OKS
| $7.51M | 0.02% |
142,600
+131,500
| +1,185% | +$6.93M |
|
956
ON Semiconductor
ON
$31.8B
| $7.51M | 0.02% |
+910,896
| New | +$6.64M |
|
957
Pilgrim's Pride
PPC
$6.4B
| $7.41M | 0.02% |
+456,013
| New | +$7.15M |
|
|
ISIL
958
DELISTED
Intersil Corp
ISIL
| $7.4M | 0.02% |
645,238
+233,400
| +57% | +$2.54M |
|
|
OWW
959
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $7.4M | 0.02% |
1,030,100
+283,800
| +38% | +$2.22M |
|
|
DRE
960
DELISTED
Duke Realty Corp.
DRE
| $7.39M | 0.02% |
+491,500
| New | +$7.67M |
|
|
PXD
961
DELISTED
Pioneer Natural Resource Co.
PXD
| $7.38M | 0.02% |
+40,088
| New | +$7.72M |
|
|
LONG
962
DELISTED
ELONG, INC. AMERICAN DEPOSITARY SHARES
LONG
| $7.37M | 0.02% |
360,000
-3,600
| -1% | -$71.5K |
|
963
McKesson
MCK
$102B
| $7.33M | 0.02% |
45,400
-516,600
| -92% | -$79.3M |
|
|
SSRI
964
DELISTED
Silver Standard Resources
SSRI
| $7.32M | 0.02% |
1,051,083
-259,500
| -20% | -$1.57M |
|
|
ACOR
965
DELISTED
Acorda Therapeutics
ACOR
| $7.31M | 0.02% |
+2,087
| New | +$8.14M |
|
966
BOK Financial
BOKF
$8.85B
| $7.3M | 0.02% |
110,042
-12,300
| -10% | -$778K |
|
|
HSNI
967
DELISTED
HSN, Inc.
HSNI
| $7.28M | 0.02% |
116,800
+112,400
| +2,555% | +$6.36M |
|
|
PRCP
968
DELISTED
Perceptron Inc
PRCP
| $7.25M | 0.02% |
522,600
+69,175
| +15% | +$812K |
|
969
Power Integrations
POWI
$3.57B
| $7.25M | 0.02% |
259,600
+203,200
| +360% | +$5.49M |
|
970
Hexcel
HXL
$7.74B
| $7.24M | 0.02% |
162,000
-197,100
| -55% | -$8.33M |
|
|
NBL
971
DELISTED
Noble Energy, Inc.
NBL
| $7.24M | 0.02% |
+106,300
| New | +$7.53M |
|
972
National CineMedia
NCMI
$252M
| $7.22M | 0.02% |
36,180
-390
| -1% | -$72.6K |
|
973
Argan
AGX
$8.02B
| $7.2M | 0.02% |
261,400
-31,900
| -11% | -$746K |
|
974
Sally Beauty Holdings
SBH
$1.55B
| $7.2M | 0.02% |
238,100
-228,400
| -49% | -$6.25M |
|
|
PFSW
975
DELISTED
PFSweb, Inc.
PFSW
| $7.2M | 0.02% |
793,539
+44,086
| +6% | +$340K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.